Enzolytics Inc.
ENZC
Rank in Stocks
#32561
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is... Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The company possesses patented anti-HIV treatments that have successfully completed clinical testing. Additionally, Enzolytics has developed a unique methodology for manufacturing human IgG1 monoclonal antibodies, intended to provide non-toxic passive immunotherapy against various infectious diseases. A significant achievement includes the creation of a proprietary cell line, specifically engineered to produce human monoclonal antibodies that effectively target and neutralize the human immunodeficiency virus (HIV).
Share Price
$0.0003
Last synced: 2026-11-09
Market Cap
$1.45M
Change (1 day)
-25.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Enzolytics Inc. (ENZC)
Category
Healthcare
EPS for Enzolytics Inc. (ENZC)
EPS as of June 2025 TTM: $0.00
According to Enzolytics Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Enzolytics Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 0.00 | -57.14% |
| 2023 | 0.00 | -30.00% |
| 2022 | 0.00 | 400.00% |
| 2021 | 0.00 | -94.44% |
| 2020 | 0.00 | -460.00% |
| 2019 | 0.00 | -122.22% |
| 2018 | 0.00 | 1,400.00% |
| 2017 | 0.00 | -94.00% |
| 2016 | $-0.01 | -88.64% |
| 2015 | $-0.04 | -27.87% |
| 2014 | $-0.06 | 52.50% |
| 2013 | $-0.04 | -99.99% |
| 2012 | $-480.00 | 3,100.00% |
| 2011 | $-15.00 | -97.23% |
| 2010 | $-541.66 | 111.07% |
| 2009 | $-256.63 | 115.82% |
| 2008 | $-118.91 | -23.43% |
| 2007 | $-155.29 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -7,830,100.00% |
US
|
|
| $-7.07 | 3,534,900.00% |
US
|
|
| $-5.29 | 2,644,900.00% |
AU
|
|
| $12.88 | -6,440,150.00% |
BE
|
|
| $21.56 | -10,780,100.00% |
NL
|
Questions about Enzolytics Inc.'s earnings per share (EPS)
What is Enzolytics Inc.'s earnings per share (EPS)?
Enzolytics Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2025.
What was Enzolytics Inc.'s earnings per share (EPS) in 2025?
In 2025, Enzolytics Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Enzolytics Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Enzolytics Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Enzolytics Inc.'s earnings per share (EPS) compare with similar companies?
Enzolytics Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.